Published: 2 September 2015
Author(s): Homayoun L. Daneschvar, Mark D. Aronson, Gerald W. Smetana

Alzheimer's disease is the most common cause of dementia and occurs commonly in patients 65 and older. There is an urgent need to find an effective management that could help prevent or at least slow down the progress of this major public health problem. Cholesterol related pathways might play a role in the pathogenesis of Alzheimer's disease. Treatment with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) has been suggested to promote the prevention of Alzheimer's disease.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.